Myeloperoxidase cytochemistry using 2,7-fluorenediamine I. BENAVIDES1 AND D. CATOVSKY MRC Leukaemia Unit, Royal Postgraduate Medical School, Ducane Road, London W12 OHS The myeloperoxidase cytochemical reaction has been well established as a valuable tool in the characterisation of various types of leucocytes. This method helps in the distinction between acute myeloid leukaemias (AML) and acute lymphoblastic leukaemias (ALL) as suggested in the French, American, and British (FAB) classification (Bennett et al., 1976) .
The most common substrates used are benzidine derivatives (Graham, 1918; Goodpasture, 1919) . We have been using benzidine dihydrochloride (BDC) according to Kaplow's (1965) technique. However, the known carcinogenic potential of these substrates has led to the widespread removal of these reagents for clinical use in the United States, United Kingdom, and Japan. Inagaki et al. (1976) reported the use of the diamine derivative of fluorene: 2,7-fluorenediamine (2,7-FDA) as a good substitute of benzidine for the demonstration of myeloperoxidase in peripheral blood and bone marrow samples.
We have compared qualitatively and quantitatively both reactions in order to assess objectively the usefulness of the new reagent.
Material and method
Freshly made bone-marrow films from 10 cases were used: AML at presentation (6), AML in remission (1), chronic granulocytic leukaemia in blast crisis (CGL-BC) (1), polycythaemia rubra vera (PRV) (1), and ALL (2).
Duplicate films were tested with: (a) the reaction of Kaplow as detailed in Dacie and Lewis (1975) , with BDC, and (b) the technique of Inagaki et al. (1976) with 2,7-FDA. No loss of enzyme activity was observed when the films were stored unfixed for up to 10 days at 4VC.
The technique of Inagaki et al. (1976) Films were fixed for one minute, washed in distilled water, and transferred to a coplin jar containing the incubation mixture. After five minutes' incubation at room temperature, they were washed in distilled water for a few seconds, shaken off to remove the excess water, and counterstained in the Giemsa solution for 15 minutes. Finally, they were washed, dried in the air, and mounted using a conventional mounting medium (Diatex, R. A. Lamb). The incubation mixture was stable for more than six weeks when stored at room temperature without the addition of H202.
Results

QUALITATIVE ASPECTS
With 2,7-FDA, the peroxidase activity was expressed in the positive myeloid cells as yellowish-brown granules in the thin parts of the films and as black or dark brown granules in the thicker parts. All neutrophils and some monocytes showed a distinct fine granulation. Eosinophils and basophils showed large positive granules.
In AML, the positive blast cells had often small or fine granules, and in some cases larger granules along with positive Auer rods were clearly seen ( Figure) .
The reaction product appeared always stronger when BDC was used as a substrate. However, the morphological recognition of the blasts was easier when 2,7-FDA was used. The reaction with 2,7-FDA was, in general, clean and never overwhelmed the cell surface with precipitates or crystals. In contrast, with the BDC method, formation of precipitates and crystals was often seen. 
QUANTITATIVE RESULTS
The percentages of positive cells using both techniques were compared in AML ( (Griswold et al., 1966) , but it is not registered as a known or suspected A non-carcinogenic substrate, the Hanker-Yates mixture (p-phenylene diamine HCI, 1 part; pyrocatechol, 2 parts) has been recommended as an alternative to diamino-benzidine for the demonstration of horseradish peroxidase (Hanker et al., 1977) . In our hands, the myeloperoxidase reaction was weak or negative with this reagent when the other techniques were clearly positive. Even when the reaction was positive, it was not well localised in the cell cytoplasm. Therefore this reagent is of no value in studies of blood and bone-marrow samples.
Letters to the Editor
Use of low ionic strength salt solution in compatibility testing
There have recently been several publications, starting with that of Low and Messeter (1974) , concerning the use of low ionic strength salt solution (LISS) in antibody identification procedures and when cross-matching (Wicker and Wallas, 1976; Lincoln and Dodd, 1978) . Other authors are mentioned in the text below.
In November 1977, we published in our regional booklet 'Technical Notes on Blood Transfusion' details of our own LISS methods and, prompted by the recent publication by Ross and Ducie (1978) , we should like briefly to record our findings.
The standard methods of crossmatching that we recommend to hospital blood banks in our region are those described by Tovey and Jenkins (1967) in The techniques used were LISS indirect antiglobulin tests with 5-minute, 10-minute, 15-minute, and 20-minute incubation times and an indirect antiglobulin test using physiological (0 14M) saline incubating for 60 minutes. All tests were performed by the slide technique. The results are expressed in Table 2 as the percentage of antibodies giving reactions by LISS antiglobulin tests which are (A) better than, (B) equal to, or (C) not as good as the conventional test. Seven sera did not react as well by the LISS antiglobulin test, using a 10-minute incubation time, as by the conventional antiglobulin test. These sera contained anti-Kell antibodies (3), anti-Fya(2), anti-D, and anti-Leb. In all seven cases the reactions were only marginally weaker by the 10-minute LISS antiglobulin test.
The benefits obtained in increasing the incubation time from 5 to 10 minutes can be clearly seen from the table. Furthermore, two weak anti-Kell sera did not re-
